Published in Mol Cancer on November 24, 2015
Evidence for the involvement of sphingosine-1-phosphate in the homing and engraftment of hematopoietic stem cells to bone marrow. Oncotarget (2015) 0.82
Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities. Oncotarget (2016) 0.76
Vitronectin in the ascites of human ovarian carcinoma acts as a potent chemoattractant for ovarian carcinoma: Implication for metastasis by cancer stem cells. J Cancer Stem Cell Res (2016) 0.75
Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT). Purinergic Signal (2016) 0.75
Does it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer? Clin Transl Med (2016) 0.75
Sheath Cell Invasion and Trans-differentiation Repair Mechanical Damage Caused by Loss of Caveolae in the Zebrafish Notochord. Curr Biol (2017) 0.75
Novel pleiotropic effects of bioactive phospholipids in human lung cancer metastasis. Oncotarget (2017) 0.75
Purinergic Signalling: Therapeutic Developments. Front Pharmacol (2017) 0.75
Immunity, inflammation, and cancer. Cell (2010) 28.27
Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol (2004) 3.43
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J (2001) 2.55
Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One (2008) 2.51
Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal (2012) 2.13
Why cancer and inflammation? Yale J Biol Med (2006) 2.13
P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp Ther (2000) 1.85
Chemotherapy induces ATP release from tumor cells. Cell Cycle (2009) 1.83
Cancer and the complement cascade. Mol Cancer Res (2010) 1.64
Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal (2010) 1.52
P2X7 mediates ATP-driven invasiveness in prostate cancer cells. PLoS One (2014) 1.48
Kinin-B1 and B2 receptor activity in proliferation and neural phenotype determination of mouse embryonic stem cells. Cytometry A (2015) 1.42
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol (2012) 1.38
AMP is an adenosine A1 receptor agonist. J Biol Chem (2012) 1.36
Microglial migration mediated by ATP-induced ATP release from lysosomes. Cell Res (2012) 1.25
Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. Immunity (2015) 1.22
Purinergic signalling and cancer. Purinergic Signal (2013) 1.18
Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities. Crit Rev Biochem Mol Biol (2014) 1.18
Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis (2011) 1.17
Many faces of DAMPs in cancer therapy. Cell Death Dis (2013) 1.11
Nucleotides in the eye: focus on functional aspects and therapeutic perspectives. J Pharmacol Exp Ther (2013) 1.08
ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol (2003) 1.08
Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy. Mol Cancer Res (2013) 1.07
Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy. Mol Cancer Res (2014) 0.95
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. Exp Hematol (2010) 0.95
Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy. J Ovarian Res (2013) 0.95
Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis. Oncogene (2014) 0.92
Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin. Int J Neuropsychopharmacol (2012) 0.92
Mechanisms of cancer metastasis: involvement of cancer stem cells? Minerva Med (2010) 0.89
Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7. Eur J Pharmacol (2012) 0.89
Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells. Purinergic Signal (2014) 0.89
Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells. Cancer Lett (2014) 0.86
Extracellular ATP activates MAP kinase cascades through a P2Y purinergic receptor in the human intestinal Caco-2 cell line. Biochim Biophys Acta (2009) 0.85
Binding of ATP to vascular endothelial growth factor isoform VEGF-A165 is essential for inducing proliferation of human umbilical vein endothelial cells. BMC Biochem (2011) 0.84
Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration. Purinergic Signal (2011) 0.84
Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview. J Biomed Biotechnol (2012) 0.83
The overlapping roles of antimicrobial peptides and complement in recruitment and activation of tumor-associated inflammatory cells. Front Immunol (2015) 0.83
Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy. J Ovarian Res (2015) 0.83
P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells. Breast Cancer Res (2014) 0.82
Adenosine inhibits tumor cell invasion via receptor-independent mechanisms. Mol Cancer Res (2014) 0.82
ATP sensitizes H460 lung carcinoma cells to cisplatin-induced apoptosis. Chem Biol Interact (2010) 0.81
Induction of senescence by adenosine suppressing the growth of lung cancer cells. Biochem Biophys Res Commun (2013) 0.81
Rab5 regulates internalisation of P2X4 receptors and potentiation by ivermectin. Purinergic Signal (2012) 0.79
The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy. Ren Fail (2014) 0.78
Signal transduction pathways associated with ATP-induced proliferation of colon adenocarcinoma cells. Biochim Biophys Acta (2010) 0.78
Adenosine triphosphate (ATP) enhances the antitumor effect of etoposide (VP16) in lung cancer cells. Oncol Rep (2004) 0.76
Long-term toxicity of chemotherapy and radiotherapy in lymphoma survivors: optimizing treatment for individual patients. Clin Adv Hematol Oncol (2015) 0.76
P2X receptors in maintenance and differentiation of neural progenitor cells. Neural Regen Res (2014) 0.83
Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy. J Ovarian Res (2015) 0.83
Novel evidence that pituitary gonadotropins directly stimulate human leukemic cells-studies of myeloid cell lines and primary patient AML and CML cells. Oncotarget (2016) 0.82
Brain nitric oxide production by a proline-rich decapeptide from Bothrops jararaca venom improves baroreflex sensitivity of spontaneously hypertensive rats. Hypertens Res (2010) 0.78
The central nervous system as target for antihypertensive actions of a proline-rich peptide from Bothrops jararaca venom. Cytometry A (2010) 0.78
Identification of aptamers as specific binders and modulators of cell-surface receptor activity. Methods Mol Biol (2013) 0.78
The potential of combined immunotherapy and antiangiogenesis for the synergistic treatment of advanced NSCLC. J Thorac Oncol (2016) 0.78
Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies. Int J Cancer (2015) 0.77
Variations of ATP and its metabolites in the hippocampus of rats subjected to pilocarpine-induced temporal lobe epilepsy. Purinergic Signal (2016) 0.76
The Involvment of Hematopoietic-Specific PLC -β2 in Homing and Engraftment of Hematopoietic Stem/Progenitor Cells. Stem Cell Rev (2016) 0.75
Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1. Int J Oncol (2016) 0.75
Brilliant Blue-G but not Fenofibrate Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease. Cell Transplant (2017) 0.75
Decreased Frequencies of Peripheral Blood CD4+CD25+CD127-Foxp3+ in Patients with Graves' Disease and Graves' Orbitopathy: Enhancing Effect of Insulin Growth Factor-1 on Treg Cells. Horm Metab Res (2017) 0.75
Interference of ursolic acid treatment with glioma growth: an in vitro and in vivostudy. Eur J Pharmacol (2017) 0.75
Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project. Adv Med Sci (2017) 0.75
Increased cytokines production and oxidative stress are related with purinergic signaling and cell survival in post-thyroidectomy hypothyroidism. Mol Cell Endocrinol (2019) 0.75